Center for Scientific Review; Notice of Closed Meetings, 54586-54587 [2020-19317]

Download as PDF 54586 Federal Register / Vol. 85, No. 171 / Wednesday, September 2, 2020 / Notices use of e-discovery technology with other HHS staff and operating divisions. e. Identifies and supports the implementation of best practices for litigation management, e-discovery, and virtual staffing across OGC. C. Functions, Authorities and Responsibilities of the Regions The Chief Counsel of each Region is HHS’ legal representative in that Region. Regional offices within OGC provide a full range of legal services including, by way of example, legal counsel to their departmental clients and client agencies in the regions, as described below, subject to the professional supervision and direction of the General Counsel. The Office of the General Counsel’s ten regional offices provide legal advice, administrative and judicial litigation support and counseling services to the regional components of the Department. Regional attorneys provide general law support to regional clients and handle work in most areas within HHS’ jurisdiction with particular emphasis on litigation for, among others, CMS, ACF, OCR, CDC, and IHS. Regional offices also provide leadership with respect to bankruptcy cases. In the area of civil rights, they work in close consultation with the Associate General Counsel for the Civil Rights Division to ensure that the regional positions align closely with those of the Division thereby fostering national uniformity. In other areas, the Divisions and Regions work collaboratively to provide consistent, uniform legal advice. Dated: August 27, 2020. Alex M. Azar II, Secretary, Department of Health and Human Services. [FR Doc. 2020–19325 Filed 8–28–20; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSKJLSW7X2PROD with NOTICES National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, VerDate Sep<11>2014 17:33 Sep 01, 2020 Jkt 250001 and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Neurological Sciences Training Initial Review Group; NST–1, Subcommittee NST–1. Date: September 21–22, 2020. Time: 9:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NSC, 6001 Executive Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS, NIH, NSC, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892– 9529, (301) 496–0660, benzingw@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, NST–1 Member Conflict Review Panel. Date: September 22, 2020. Time: 1:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NSC, 6001 Executive Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS, NIH NSC, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892– 9529, (301) 496–0660, benzingw@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: August 27, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–19318 Filed 9–1–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Behavioral Medicine, Interventions and Outcomes Study Section. Date: October 5–6, 2020. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Mark Allen Vosvick, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892, 301–402–4128, mark.vosvick@nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Behavioral Genetics and Epidemiology Study Section. Date: October 6–7, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Andrew Louden, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20817, 301–435–1985, loudenan@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; S10 Programs for Shared Instrumentation Grant (SIG) and Shared Instrumentation for Animal Research (SIFAR) Grant. Date: October 6, 2020. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jan Li, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5106, Bethesda, MD 20892, 301.402.9607, Jan.Li@ nih.gov. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Molecular Oncogenesis Study Section. Date: October 7–8, 2020. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\02SEN1.SGM 02SEN1 Federal Register / Vol. 85, No. 171 / Wednesday, September 2, 2020 / Notices Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nywana Sizemore, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 20892, 301–435– 1718, sizemoren@csr.nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Mechanisms of Sensory, Perceptual, and Cognitive Processes Study Section. Date: October 7–8, 2020. Time: 9:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301–435– 1242, kgt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 27, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–19317 Filed 9–1–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2020–0490] Commercial Fishing Safety Advisory Committee; Meeting U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of Federal Advisory Committee virtual meeting. AGENCY: The Commercial Fishing Safety Advisory Committee (Committee) will meet via a virtual meeting to discuss voluntary guidelines for the prevention of falls overboard situations, as described in task statement #01– 19(b). The virtual meeting will be open to the public. DATES: Meeting. The Committee is scheduled to meet virtually on Thursday, September 24, 2020, from 1 p.m. to 3 p.m. Eastern Daylight Time. Please note that this virtual meeting may adjourn early if the Committee has completed its business. jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:33 Sep 01, 2020 Jkt 250001 Comments and supporting documents: To ensure your comments are received by Committee members before the virtual meeting, submit your written comments no later than September 17, 2020. ADDRESSES: To join the virtual meeting or to request special accommodations, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section no later than 1 p.m. on September 17, 2020. Instructions: You are free to submit comments at any time, including orally at the virtual meeting as time permits, however, if you desire that the Committee members review your comments before the virtual meeting, please submit your comments no later than September 17, 2020. We encourage you to submit comments through the Federal eRulemaking Portal at https:// www.regulations.gov. If your material cannot be submitted using https://www/ regulations.gov, call or email the individual in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. You must include the docket number [USCG–2020–0490]. Comments received will be posted without alteration at https://www.regulations.gov, including any personal information provided. For more about privacy and submissions in response to this document, see DHS’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). If you encounter technical difficulties with comment submission, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Docket Search: Documents mentioned in this notice as being available in the docket, and all public comments, will be in our online docket at https:// www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign-up for email alerts, you will be notified when comments are posted. FOR FURTHER INFORMATION CONTACT: Mr. Jonathan Wendland, Alternate Designated Federal Officer (ADFO) of the Commercial Fishing Safety Advisory Committee, telephone (202) 372–1245, or email at CGFishsafe@uscg.mil. SUPPLEMENTARY INFORMATION: Notice of this meeting is in compliance with the Federal Advisory Committee Act, (5 U.S.C., Appendix). The Commercial Fishing Safety Advisory Committee is authorized by Title 46 United States Code Section 4508. The Committee’s purpose is to provide advice and recommendations to the United States Coast Guard and the PO 00000 Frm 00056 Fmt 4703 Sfmt 9990 54587 Department of Homeland Security on matters relating to the safe operation of commercial fishing industry vessels. Agenda The agenda for the September 24, 2020, virtual meeting is as follows: • Introduction. • Roll call of Committee members and determination of a quorum. • Comments by Designated Federal Officer (DFO). • Comments by ADFO. • Comments by the Committee Chairman. • Comments by Federal Advisory Committee Representative. • Old Business from the 40th Commercial Fishing Safety Advisory Committee meeting. • Comments by U.S. Coast Guard Office of Standards Evaluation and Development. • Comments by CG–NAV–3. • New Business. • Comments by Committee Chairman. • Public comment period. • Discussion: Task # 01–19(b)— Lifesaving/Man Overboard (MOB) Voluntary Best Practice Guide. • Public comment period. • Comments by DFO. • Comments by Committee Chairman. • Adjournment of meeting. A copy of all pre-meeting documentation will be available at https://www.dco.uscg.mil/fishsafe no later than September 21, 2020. Alternatively, you may contact Mr. Jonathan Wendland as noted in the FOR FURTHER INFORMATION CONTACT section above. During the September 24, 2020, virtual meeting, public comments will be limited to three minutes per person. Please note that the public comment period may end before the period allotted, following the last call for comments. Please contact the individual listed in the FOR FURTHER INFORMATION CONTACT section above to register as a speaker prior to September 22, 2020. Dated: August 28, 2020. Wayne R. Arguin Jr., Captain, U.S. Coast Guard, Director of Inspections and Compliance. [FR Doc. 2020–19400 Filed 9–1–20; 8:45 am] BILLING CODE 9110–04–P E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 85, Number 171 (Wednesday, September 2, 2020)]
[Notices]
[Pages 54586-54587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19317]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Behavioral Medicine, Interventions and 
Outcomes Study Section.
    Date: October 5-6, 2020.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark Allen Vosvick, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892, 301-
402-4128, [email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Behavioral Genetics and Epidemiology Study 
Section.
    Date: October 6-7, 2020.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Andrew Louden, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3137, Bethesda, MD 20817, 301-435-1985, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; S10 Programs for Shared Instrumentation Grant (SIG) and 
Shared Instrumentation for Animal Research (SIFAR) Grant.
    Date: October 6, 2020.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jan Li, MD, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5106, Bethesda, MD 20892, 301.402.9607, 
[email protected].

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Molecular Oncogenesis Study Section.
    Date: October 7-8, 2020.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 54587]]

    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Nywana Sizemore, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 
20892, 301-435-1718, [email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Mechanisms of Sensory, 
Perceptual, and Cognitive Processes Study Section.
    Date: October 7-8, 2020.
    Time: 9:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-19317 Filed 9-1-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.